B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors | |
Zhao, Xingli; Zhang, Zhuoran; Moreira, Dayson; Su, Yu-Lin; Won, Haejung; Adamus, Tomasz; Dong, Zhenyuan; Liang, Yong; Yin, Hongwei H.; Swiderski, Piotr | |
2018 | |
卷号 | 26期号:3页码:695-707 |
关键词 | CpG oligonucleotides STAT3 TLR9 immunotherapy lymphoma |
ISSN号 | 1525-0016 |
DOI | 10.1016/j.ymthe.2018.01.007 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6360528 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhao, Xingli,Zhang, Zhuoran,Moreira, Dayson,et al. B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors[J],2018,26(3):695-707. |
APA | Zhao, Xingli.,Zhang, Zhuoran.,Moreira, Dayson.,Su, Yu-Lin.,Won, Haejung.,...&Kortylewski, Marcin.(2018).B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.,26(3),695-707. |
MLA | Zhao, Xingli,et al."B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors".26.3(2018):695-707. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论